IgA-nefropátia: vizsgálatok itt: Kolumbia

3 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

  Where

  Barranquilla, Medellín

  Életkor

  2 év to 18 év

  People

  28 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07498335
• 3. fázisTaking people
  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  Where

  Barranquilla, Bogotá, Cali, Zipaquirá

  Életkor

  18 év and over

  People

  454 worldwide

  Run by

  Biogen

  See details and how to joinNCT06935357 · EU 2024-519345-30-00
• 3. fázisTaking people
  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Where

  Barranquilla, Medellín

  Életkor

  18 év to 100 év

  People

  540 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04557462 · EU 2023-508690-92-00